Company news
OptimizeRx Corporation news in 2023
OptimizeRx Corporation's news releases, calls and decks from 2023, newest first.
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
December 17, 2023
OptimizeRx Reports Third Quarter 2023 Financial Results
November 5, 2023
OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8: 30 a.m. ET
October 24, 2023
OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers
October 11, 2023
OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform
September 25, 2023
OptimizeRx Expands AI Powered Omnichannel Platform
August 23, 2023
OptimizeRx Reports Second Quarter 2023 Financial Results
August 13, 2023
OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4: 30 p.m. ET
July 30, 2023
OptimizeRx’s CEO Provides 2023 Midyear Strategic Update
May 23, 2023
OptimizeRx’s Karina Castagna Named One of the 2023 PM360 ELITE 100
May 17, 2023
OptimizeRx Reports First Quarter 2023 Financial Results
May 9, 2023
Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance
May 1, 2023
OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4: 30 p.m. ET
April 25, 2023
OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report
April 3, 2023
Financial Times Ranks OptimizeRx Amongst The Americas’ Fastest Growing Companies for the Fourth Consecutive Year
March 28, 2023
OptimizeRx Authorizes $15 Million Share Repurchase Program
March 13, 2023
OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients
March 8, 2023
OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results
March 7, 2023
OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4: 30 p.m. ET
February 22, 2023
OptimizeRx’s Karina Castagna Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars
February 8, 2023
OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference
January 3, 2023